|
1-888-WINSHIP 1365C Clifton Road |
|
2006 WCI Research Symposium Poster Session
The 4th Annual Winship Scientific Symposium and poster session was held on Thursday, October 26 and featured research done by members of the WCI scientific programs and core facilities. The poster session offered a great environment for scientists to discuss research, form collaborations and build team science interactions. Thank you to everyone who presented posters at this year's event. We received excellent response to our call for research posters. Please scroll down to see the posters submitted by the poster session participants. Brain Tumor Program 1. Synthesis, Radiolabeling and In Vivo Evaluation of Syn-[18]FACBC As A Potential Tumor Imaging Agent 2. Investigation Strategies of Glioblastoma Multiforme: Impact on Clinical Outcomes 3. CSCRF/SDF-1 Axis Promotes VEGF-mediated Tumor Angiogenesis Through Akt and MAPK Signaling Pathways 4. Improved Focal Radiotherapy Treatment of High-Grade Gliomas with Magnetic Resonance Spectroscopy-Aided Target Delineation 5. Anti-Tumor Activity of a New Class of Small Molecules Selectively Targeting the Hypoxia/HIF Pathway 6. Hypoxia and Genetic Upregulation of Tissue Factor Expression in Glioblastoma and its Role in !%Pseudopalisading!& Necrosis Development 7. Novel Nanocarriers for Brain Tumor Imaging and Treatment 8. Nuclear Localization as a Mechanism for Inhibiting the Tumor Suppressor Properties of PTEN 9. MicroPET Measurement of Delivery to Brain of Brain Cancer Drug Candidates (2ME2, 2FEE2, KCN-1) 10. A Novel p53-Independent Function for p14ARF: The Regulation of Tumor Angiogenesis
11. Establishment of a Rapamycin-Resistant Cell Line that Retains Sensitivity to PI3 Kinase Inhibitors 12. Inhibition of NFkB by a Novel Curcumin Analogue 13. KLF5 Interacts w/ P53 in Regulating Survivin Expression in Acute Lymphoblastic Leukemia 14. Development of Novel Small Molecule Inhibitors Targeting CXCR4 Against Cancer Metastasis 15. Expression of Livin, A Novel Member of the Inhibitor-of-Apoptosis Protein (IAP) Family, in Neuroblastoma: Possible Prognostic Significance 16. FGFR3 Activated p90RSK2 to Mediate Hematopoietic Transformation by a Novel Two-Step Mechanism 17. b2-Microglobulin Promotes the Growth of thuman Renal Cell Carcinoma Through the Activation of the Protein Kinase A, Cyclic AMP Responsive Element Binding Protein and Vascular Endothelial Growth Factor Axis 18. FTIs Impair Chromosomal Maintenance in Cell Lines and Human Tumors by Compromising CENP-E and !VF Functionality and Disrupting Kinetochore Capture 19. Direct Interaction of Histone Deacetylase-6 with HIF-1 Alpha Regulates Survivin Gene Transcription Independent from its Deacetylase Activity 20. The NSCLC Tumor Supressor LKB1 Functions in Actin-Dependent Cancer Cell Motility 21. 14-3-3 Functions as a General Integrator of Pro-Survival Signals in Hematopoietic Transformation by Diverse Leukemogenic Fusion/Mutant Tyrosine Kinases 22. MAPK36 Regulates ASKa Through a 14-3-3-Mediated Ternary Complex Cancer Control and Population Sciences 23. The Role of Patient Adherence in Maintenance of Results After Lymphedema Therapy 24. Bcl-2, Bax, Bak Levels in Colon Crypts and Colon Cancer Risk Factors in the Markers of Adenomatous Polyps II Case-Control Study 25. TGFalpha and TGFbeta1 Levels in Colon Crypts, Colon Cancer Risk Factors, and Incident, Sporadic Colorectal Adenomas in the Markers of Adenomatous Polyps II (MAPII) Case-Control Study 26. Expression of APC in Normal-Appearing Rectal Mucosa Differs Between Those With and Without Incident, Sporadic Colorectal Adenomatous Polyps and May be Modulated by Diet: Results From the Markers of Adenomatous Polyps II (MAPII) Case-Control Study 27. Enhanced Psychosocial Stress-Induced IL-6 Responses are Associated with Attenuated Stress-Induced Cortisol Responses in Patients with Major Depression and Increased Early Life Stress 28. Induction of MAPK-p38 After the First Injection of Interferon Q Predicts Severity of Interferon-alpha-Induced Depressive Symptoms in Patients with Hepatitis C Infection 29. Cilomilast, a Phosphodiesterase Type 4 Inhibitor, Increases Glucocorticoid Receptor Function through Activation of Protein Kinase A Pathways 30. Paroxetine for the Prevention of Depression in Patient Receiving Interferon-alpha Plus Ribavirin for Hepatitis C 31. Expression of TGFalpha1 in Normal-Appearing Rectal Mucosa in Individuals with and without Sporadic Colorectal Adenomatous Polyps 32. A Relationship Between the Neuroendocrine Response and CSF HVA Concentrations to Depressive-Like Behavioral Alterations During INF alpha Administration in Rhesus Monkeys Cancer Genomic and Genetic Instability 33. DNA Damage Induced ROS Response in Saccharomyces cerevisiae 34. Rapid Screening Tool for Cytotoxic DNA Damaging Agetns and Radiation Sensitization 35. Transcriptional Mutagenesis: New Insights into DNA Repair Pathways 36. Prediction of Aberrant CpG Island Methylation in Cancer 37. Development and Optimization of a High Throughput Kinetic Assay for BRCA1 Associated Protein 1 (MAP1) 39. Characterization of Nup98/DDX10, a chimeric protein associated with Acute Myelogenous Leukemia. Songli Xu and Maureen A. Powers Prostate Cancer 39. Salvage Reostatectomy for Prostate Cancer: Data from the Surveillance Epidemiology & End Results Registry 40. Initial Experience with the PET Radiotracer Anti-1-Amino-3-[18F]fluorocyclobutane-1-carboxylic acid (anti[18F]FACBC) in Newly Diagnosed Prostate Cancer 41. Human Prostate Cancer Interaction with Bone-Specific Microenvironment Promotes Epithelial-Mesenchymal Transition and Increased Bone Metastatic Potential 42. Honokiol, A Natural Product from Plan, Inhibits the Bone Metastatic Growth of Human Prostate Cancer Cells 43. Association of a Homozygous 2-bp Deletion in snoRNA U50 with Human Prostate Cancer 44. Beta2 Microglobulin as a Regulator of Androgen Receptor and Survival in Prostate Cancer Cells 45. A Moderately Low Phosphate Diet Reduces Tumor Burden in a mouse Model of Skin Tumorigenesis 46. Hormonal and Developmental Regulation of Micro-RNA's in Prostate Cancer Cells 47. Rap1: A Link Between Hypoxia, Prostate Cancer Progression and Metastasis 48. Pro-proliferative Transcription Factor KLF5 is a Cofactor Mediating TGFb's inhibitory Function in Epithelial Cells 49. ADAM9 Plays an Important Role in Prostate Cancer Survival and Responds Differently to Different Reactive Oxygen Species Mediated Cell Kill 50. Soluble METCAM/MUC18 Blocks Tumor-Angiogenesis and Tumorigenesis of Human Prostate Cancer LNCaP Cells 51. VEGF Autocrine Signaling is a Survival Pathway in Bone-Metastatic Human Prostate Cancer Cells Breast Cancer Program 52. Deletion, Mutation and Decreased Expression of ATBF1 in Human Breast Cancer 53. Recepto-Targeted Magnetic Iron Oxide Nanoparticles for In Vivo MRI of Breast Cancer 54. Simultaneous and Quantitative Detection of Multiple Biomarkers in Human Breast Cancers Using Semiconductor Multicolor Quantum Dots 55. Restoration of Tamoxifen Sensitivity in ER-negative Breast Cancer Cells: Tamoxifen-bound Reactivated Estrogen Receptor Recruits Distinct Chromatin Modifying Corepressor Complexes 56. Modulation of Distinct Co-Regulator Proteins Contribute to Tamoxifen Resistance 57. Inhibition of mTOR Pathway Enhances Sensitivity of Breast Cancer Triple Negative Cell Lines to Erlotinib 58. Computational Methods for the Study of Tomogrpahic Breast Imaging 59. Galectin-3 Modulates Nitric Oxide-Induced Adhesion and Migration of Breast Cancer Cells Aerodigestive and Lung Cancer 60. The Akt Inhibitor, Perifoxine, Induces Growth Arrest & Apoptosis of Human Lung Cancer Cells Involving Cox-2 Activation 61. PPARfx Ligands Induce Death Receptor 5 (DR5) Expression and Distribution on Cell Surface and Enhance TRAIL-Induced Apoptosis in Human Lung Cancer Cells 62. Synergistic Tumor Growth Inhibition by Combined Treatment with Green Tea Epigallocatechin-3-gallate (EGCG) and an Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor (TKI) Tarceva in Squamous Cell Carcinoma of the Head and Neck (SCCHN) 63. Respiratory Motion in Gastrointestinal Cancer: Implications for IMRT and Stereotactic Body Radiosurgery 64. Antitumor Effects of Combined Bortezomib and Tipifarnib in Head and Neck Squamous Cell Carcinoma (HNSCC) Cells 65. The Role of Caveolin-1 in Lymph Node Metastasis of the Head and Neck Cancer 66. LKB1 Mutation in Large Cell Carcinoma of the Lung 67. FLIP Downregulation and Its Impact on Celecoxib-induced Apoptosis in Human Lung Cancer Cells 68. Decreased Human METCAM/MUC18 Expression Correlates with the Appearance, but Its Increased Expression Correlates with the Metastasis of Nasopharyngeal Carcinomas Other 69. Inhibition of Aurora Kinases Overcomes Resistance to Paclitaxel in Ovarian Cancer 70. SOX4 Participates in an Epidermal Growth Factor Receptor Positive Feedback Loop 71. Establish a Xenograft Model of Hepatic Human Uveal Melanoma Micometastasis 72. Development of a High Throughput Assay for Tumor Heat Shock Protein 90 73. Donor DC Subsets Express Different Co-Stimulators and Influence T-cell Expansion and Survival in Allogeneic Bone Marrow Transplant 74. Frequent and Over-Expression of METCAM/MUC18 IN Human Ovarian Cancer Tissues Implicates Its Positive Role in the Progression of Clinical Ovarian Cancers 75. Homeostatic Expansion of Donor FoxP3+CD25+CD4+ Cells in Recipients of CD4+ Cells Depleted Allogeneic Hematopoietic Graft 76. Bioconjugated SERS Tags for Cancer Biomarker Detection on Cell Surfaces 77. Apoptotic Donor Leukocytes Limit Mixed-Chimerism Induced by CD40-CD154 Blockade in Allogeneic Bone Marrow Transplantation |
||